Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer - ESMO-MCBS scores
| Image |  |
|---|---|
| Description | scientific article published on 18 June 2018 |
| Author/s | |
| Publication date | June 18, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |